Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 809 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 60.23 | NA | 15,133 | 83,718 | 14,584 | ||||||||||||
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 31.34 | NA | 7,875 | 40,065 | 7,009 | ||||||||||||
| 810 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 8.43 | NA | 2,118 | 11,721 | 2,025 |
DEMOGRAPHIC DETAILS OF DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 12,684 | 83.82 |
| Black | 1,301 | 8.6 |
| Hispanic | 338 | 2.23 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 3,784 | 25.0 |
| 70 to 74 | 3,468 | 22.92 |
| 75 to 79 | 2,676 | 17.68 |
TOP ICD DIAGNOSIS CODES FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| R5081 | Fever presenting with conditions classified elsewhere | 7,433 | 49.12 |
| T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 6,088 | 40.23 |
| D709 | Neutropenia, unspecified | 4,905 | 32.41 |
TOP ICD PROCEDURE CODES FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 30233N1 | Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach | 4,638 | 30.65 |
| 30233R1 | Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach | 1,895 | 12.52 |
| 07DR3ZX | Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic | 1,174 | 7.76 |
TOP HOSPITALS ASSOCIATED WITH DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 139 | 0.92 |
| Arthur G James Cancer Hospital | 300 W 10TH AVE | Columbus | OH | 43210 | 89 | 0.59 |
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 77 | 0.51 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. JAMES N SPYCHALSKI | 600 18TH ST | PARKERSBURG | WV | 26101 | 14 | 0.09 |
| DR. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 13 | 0.09 |
| DR. SHALINI MULAPARTHI | 1730 LAKELAND HILLS BLVD | LAKELAND | FL | 33805 | 12 | 0.08 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | NA | NA |
DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2017 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2017 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2017 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | R5081 | Fever presenting with conditions classified elsewhere | 29,818 | 7,433 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | I10 | Essential (primary) hypertension | 16,672 | 6,697 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 20,582 | 6,088 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | E785 | Hyperlipidemia, unspecified | 9,120 | 5,061 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | D709 | Neutropenia, unspecified | 19,371 | 4,905 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Z87891 | Personal history of nicotine dependence | 9,401 | 4,650 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | D61810 | Antineoplastic chemotherapy induced pancytopenia | 15,423 | 4,231 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | D61818 | Other pancytopenia | 10,710 | 4,091 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | K219 | Gastro-esophageal reflux disease without esophagitis | 7,076 | 3,768 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | E876 | Hypokalemia | 8,189 | 2,839 |